Détail de l'auteur
Auteur Mouly V |
Documents disponibles écrits par cet auteur (181)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Le Bihan MC ; Bigot A ; Jensen SS ; Dennis JL ; Rogowska-Wrzesinska A ; Laine J ; Gache V ; Furling D ; Jensen ON ; Voit T ; Mouly V ; Coulton GR ; Butler Browne G | 2012Article
Riederer I ; Negroni E ; Bencze M ; Wolff A ; Aamiri A ; Silva-Barbosa SD ; Butler Browne G ; Savino W ; Mouly V | 2012Accès au résumé PubMed / to PubMed abstractArticle
Bencze M ; Negroni E ; Vallese D ; Yacoub-Youssef H ; Chaouch S ; Wolff A ; Aamiri A ; Di Santo JP ; Chazaud B ; Butler Browne G ; Savino W ; Mouly V ; Riederer I | 2012Article
Philippi S ; Bigot A ; Marg A ; Mouly V ; Spuler S ; Zacharias U | 2012Accès au résumé PubMed / to PubMed abstractArticle
Lokireddy S ; Mouly V ; Butler Browne G ; Gluckman PD ; Sharma M ; Kambadur R ; McFarlane C | 2011Accès au résumé PubMed / to PubMed abstractArticle
Duijnisveld BJ ; Bigot A ; Beenakker KG ; Portilho D ; Raz V ; van der Heide HJ ; Visser CP ; Chaouch S ; Mamchaoui K ; Westendorp RG ; Mouly V ; Butler-Browne GS ; Nelissen RG ; Maier AB | 2011Accès au résumé PubMed / to PubMed abstractArticle
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Pinto Mariz F ; Carvalho L ; Araujo A ; de Mello W ; Ribeiro M ; Cunha MDC ; Riederer I ; Negroni E ; Mouly V ; Voit T ; Desguerre I ; Butler Browne G ; Savino W ; Silva-Barbosa SD | 2011Background. Duchenne muscular dystrophy (DMD) affects 1:3,500 male births, and is caused by mutations in the dystrophin gene. Even though the genetic mutation results in decreased resistance of muscle fibers, the immune response may contribute t[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Dumonceaux J ; Bartoli M ; Mariot V ; Vovard F ; Whalen S ; Ferreboeuf M ; Mamchaoui K ; Mouly V ; Helmbacher F ; Butler-Browne GS | 2011Facioscapulohumeral dystrophy (FSHD) is a human myopathy characterized by a progressive decrease in muscle mass and weakness in facial, upper arm, shoulder girdle and lower limb muscles, these symptoms frequently showing a right/left asymmetry. [...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Yada E ; Pinto-Mariz F ; Negroni E ; Barthelemy I ; Blot S ; Savino W ; Voit T ; Mouly V ; Butler-Browne GS | 2011Duchenne muscular dystrophy (DMD) is an X-linked muscle wasting disease caused by the absence of functional dystrophin at the sarcolemma. There is currently no therapy for this disease, but stem cell-based cell therapy, eventually in combination[...]Article
Le Bihan MC ; Le Bihan MC ; Bigot A ; Rogowska-Wrzesinska A ; Jensen SS ; Laine J ; Baraibar M ; Friguet B ; Dennis JL ; Jensen ON ; Coulton GR ; Mouly V | AFM-TELETHON | 2011With age, there is a gradual decline in the effectiveness of the regenerative response of skeletal muscle to damage which is accompanied by tissue remodeling such as muscle fiber atrophy, fibrosis and a general loss of muscle mass and function. [...]Article
Negroni E ; Vallese D ; Butler Browne G ; Trollet C ; Vilquin JT ; Butler-Browne GS ; Mouly V | 2011Accès au résumé PubMed / to PubMed abstractArticle
Mouly V ; Larghero J ; Toy-Miou M ; Eymard B ; Pascal L ; Chapon F ; Butler Browne G ; Lacau Saint Guily J | AFM-TELETHON | 2011Degenerative dystrophy of the pharyngeal muscles in OPMD causes fibrosis with swallowing disorders and a decreased relaxation of the cricopharyngeal muscle (CPM) (muscle of the upper esophageal sphincter, UES). The myotomy of the UES improves on[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Bencze M ; Negroni E ; Yacoub-Youssef H ; Chaouch S ; Wolff A ; Di Santo J ; Chazaud B ; Butler-Browne GS ; Savino W ; Mouly V ; Riederer I | 2011Cell therapy has been envisaged for some genetic muscular disorders using myoblasts in order to deliver the missing protein. Although pre-clinical trials in the mouse were promising, therapeutic trials using local injection of myoblasts failed t[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Le Bihan MC ; Bigot A ; Jensen SS ; Dennis JL ; Rogowska-Wrzesinska A ; Laine J ; Gache V ; Furling D ; Jensen ON ; Voit T ; Mouly V ; Coulton GR ; Butler Browne G | 2011Efficient muscle regeneration requires cross talk between multiple cell types via secreted signalling molecules. However, as yet there has been no comprehensive analysis of this secreted signalling network in order to understand how it regulates[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Chaouch S ; Mamchaoui K ; Trollet C ; Bigot A ; Negroni E ; Wolff A ; Kandalla P ; Marie S ; Di Santo J ; Muntoni F ; Lacau Saint Guily J ; Spuler S ; Philippi S ; Blumen S ; Furling D ; Voit T ; Wright W ; Aamiri A ; Butler-Browne GS ; Mouly V ; Kandalla PK ; Kim J ; Blumen SC ; Wright WE | AFM-TELETHON | 2011We recently generated immortalized human myoblast cell lines from control donors, by transduction of these cells with both telomerase (hTERT) and cyclin-dependent kinase 4 (CDK-4) expressing vectors. These cells maintain their potential to diffe[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Kunz S ; Bigot A ; Zacharias U ; Mouly V ; Spuler S ; Cartaud J | AFM-TELETHON | 2011Dysferlin gene mutations cause limb-girdle muscular dystrophy (LGMD) 2B and miyoshi myopathy. These muscular dystrophies are characterized by progressive muscle weakness. Dysferlin is known to play an essential role in skeletal muscle membrane r[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Erwan G ; Bigot A ; Jollet A ; Butler-Browne GS ; Mouly V ; Furling D | 2011Myotonic Dystrophy type 1 (DM1), one of the most common forms of inherited neuromuscular disorders, is caused by a (CTG)n> 40 repeat expansion in the 3'non-coding region of the DMPK gene. DM1 is an RNA-dominant disorder due to the expression of [...]Article
Degerny C ; Pinna G ; Maury Y ; Kratassiouk G ; Mouly V ; Frandsen N ; Harel-Bellan A | AFM-TELETHON | 2011MicroRNAs (miRNAs) are key molecules in cell biology. Here, we used a genome-wide miRNA loss-of-function screen based on LNA antisense oligonucleotides in order to identify miRNAs that are essential for terminal differentiation of human skeletal[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Trollet C ; Anvar S ; Venema A ; Hargreaves I ; Foster K ; Vignaud A ; Ferry A ; Negroni E ; Gidaro T ; Hourde C ; Baraibar M ; Hoen P ; Davies J ; Rubinsztein D ; Heales S ; Mouly V ; van der Maarel S ; Raz V ; Butler Browne G ; Dickson G | AFM-TELETHON | 2011Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disorder characterized by ptosis, dysphagia and proximal limb weakness. Autosomal dominant OPMD is caused by a short (GCG)8-13 expansions within the first exon of the poly(A) binding pr[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Trollet C ; Perie S ; Gidaro T ; Mamchaoui K ; Negroni E ; Bouazza B ; Svinartchouk F ; Blumen S ; Mouly V ; Lacau Saint Guily J ; Butler Browne G | AFM-TELETHON | 2011Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant inherited, slow progressing, late onset degenerative muscle disorder, characterized by progressive eyelid drooping (ptosis) and difficulties with swallowing (dysphagia). The phar[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Feferman T ; Sylvain B ; Mélinée C ; Mouly V ; Tzartos S ; Fuchs S ; Souroujon M ; Berrih-Aknin S | AFM-TELETHON | 2011Anti-acetylcholine receptor (AChR) autoantibodies target the muscle in human spontaneous MG and its induced model experimental autoimmune MG (EAMG). The aim of the study was to identify the common and specific molecular signatures of the muscle [...]Article
Belgrano A ; Rakicevic L ; Mittempergher L ; Campanaro S ; Martinelli VC ; Mouly V ; Del Valle G ; Kojic S ; Faulkner G | 2011Accès au résumé PubMed / to PubMed abstractArticle
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Vandenburgh H ; Shansky J ; Benesch-Lee F ; Skelly K ; Spinazzola J ; Green S ; Saponjian Y ; Butler Browne G ; Mouly V ; Tseng B | AFM-TELETHON | 2011Skeletal muscle weakness and fatigue disorders affect millions of individuals each year and few treatments are available. A high content physiological drug screening technology was developed using skeletal muscle myoblasts bioengineered into con[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Boutonnet C ; Bello NF ; Lamsoul I ; Métais A ; Mouly V ; Lutz P ; Moog-Lutz C | 2011Our work is based on human primary myoblast cultures derived from single satellite cells. In human, as in other species, it is well established that myoblast differentiation is mainly controlled by two families of transcription factors, the Myog[...]Article
Mamchaoui K ; Trollet C ; Bigot A ; Negroni E ; Chaouch S ; Wolff A ; Kandalla PK ; Marie S ; Di Santo J ; Lacau Saint Guily J ; Muntoni F ; Kim J ; Philippi S ; Spuler S ; Blumen SC ; Voit T ; Wright WE ; Aamiri A ; Butler-Browne GS ; Mouly V | 2011